Discover 3,059 paid clinical trials in Pennsylvania. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Pennsylvania provides numerous options to healthy volunteers looking to take part in paid research studies, as well as participants looking for condition-specific trials. Research hubs in Philadelphia, Pittsburgh, and Allentown are actively recruiting participants, giving access to groundbreaking treatments and quality healthcare.
Filter
1
Filter results
Results: 3,059
Active & Responsive
A Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic Arthritis
for
Moderate to Severe Psoriatic Arthritis
Location: Philadelphia PA, Duncansville PA, Memphis TN, Katy TX,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 18 - 70+
Code: NCT07801495
Phase 2, Recruiting
Active & Responsive
A Study of the Jovi Patch, Powered by Signal Relief, for the Improvement of General Menstrual Discomfort
for
General Menstrual Discomfort
Location: Meadowbrook PA
Sponsor: Signal Relief
Sex: Female
Age: 18 - 50
Code: NCT07825558
Recruiting
Active & Responsive
Platform Trial to Delay Stage 3 Diabetes: Comparing Teplizumab With ATG
for
Type 1 Diabetes Mellitus
Location: New Haven CT, New York NY, Pittsburgh PA,
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Sex: All
Age: 4 - 34
Code: NCT07216391
Phase 2, Recruiting
Active & Responsive
Repeat Biliary Point of Care Ultrasound for Detecting Early Acute Cholecystitis
for
Cholecystitis, Acute, Biliary Diseases
Location: York PA
Sponsor: WellSpan Health
Sex: All
Age: 18+
Code: NCT07792200
Recruiting
Active & Responsive
A 52-week Study of Remibrutinib in IgE-mediated Food Allergy
Location: Boston MA, The Bronx NY, New York NY, Riverdale NJ,
Sponsor: Novartis Pharmaceuticals
Sex: All
Age: 12 - 65
Code: NCT07768371
Phase 3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Active & Responsive
A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information
for
Clinical Stage 0 Cutaneous Melanoma AJCC v8,
Location: Philadelphia PA, Wilmington DE, Orlando FL,
Sponsor: Children's Oncology Group
Sex: All
Age: 0 - 25
Code: NCT07621614
Phase 2, Recruiting
Active & Responsive
A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus
Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
Study of LNP.UCD.ABE in Patients With Urea Cycle Disorders
for
Urea Cycle Disorders, Carbamoyl-Phosphate Synthase I Deficiency
Location: Philadelphia PA
Sponsor: Rebecca Ahrens-Nicklas
Sex: All
Age: 0 - 5
Code: NCT07667387
Phase 1, Phase 2, Recruiting
Active & Responsive
ACX-362E [Ibezapolstat] for Oral Treatment of Recurrent Clostridioides Difficile Infection
for
Clostridium Difficile Infection Recurrence
Location: Newton MA, Worcester MA, Hamden CT, Massapequa NY,
Sponsor: Acurx Pharmaceuticals Inc.
Sex: All
Age: 18 - 70+
Code: NCT07513285
Phase 2, Recruiting
Active & Responsive
A Study of Quinacrine in Participants With Cutaneous Lupus Erythematosus
for
Cutaneous Lupus Erythematosus (CLE)
Location: Philadelphia PA
Sponsor: Victoria Werth
Sex: All
Age: 18+
Code: NCT07694336
Phase 2, Recruiting
Active & Responsive
Study of Oral MRT-2359 With Apalutamide in Prostate Cancer
for
Castration-Resistant Prostate Cancer (CRPC),
Location: East Brunswick NJ, Lancaster PA, Fairfax VA, Omaha NE,
Sponsor: Monte Rosa Therapeutics, Inc
Sex: Male
Age: 18+
Code: NCT07745361
Phase 2, Recruiting
Active & Responsive
A Study to Investigate the Efficacy, Pharmacokinetics, and Safety of Mitapivat in Pediatric Participants With α- or β-Non-Transfusion-Dependent Thalassemia
for
Non-Transfusion-dependent Alpha-Thalassemia,
Location: New York NY, Philadelphia PA, Atlanta GA, Dallas TX,
Sponsor: Agios Pharmaceuticals, Inc.
Sex: All
Age: 1 - 17
Code: NCT07517133
Phase 3, Recruiting
Active & Responsive
A Study to Investigate the Efficacy, Pharmacokinetics, and Safety of Mitapivat in Pediatric Participants With Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-TDT)
for
Transfusion-dependent Alpha-Thalassemia,
Location: New York NY, Philadelphia PA, Atlanta GA, Dallas TX
Sponsor: Agios Pharmaceuticals, Inc.
Sex: All
Age: 1 - 17
Code: NCT07506863
Phase 3, Recruiting
Active & Responsive
Periprosthetic Joint Infection Bubble Study
for
Periprosthetic Joint Infection (PJI)
Location: Philadelphia PA
Sponsor: Thomas Jefferson University
Sex: All
Age: 18+
Code: NCT07599865
Phase 2, Recruiting
Active & Responsive
Mobile Health Program for Post-Preeclampsia Hypertension